Despite a fair share of warnings from the experts, no country actually seemed to have been proactive when the tragedy of Covid 19 eventually struck. It was a classic case of “this is never going to happen to us”. Spoiler alert! It did happen, and it happened on a scale that will leave its effects to be felt years down the line. The human resilience was tested like never before, and after more than a year, it looks like we are finally coming through one of the darkest periods ever witnessed in the history. There was a collective sigh of relief across the world when it was announced that Covid 19 vaccine is ready to be shipped out. That old normal looked closer than it had over the last 12 months. Vaccine administration plans were outlined, but vaccinating a world population of over 8 billion people was never going to be an easy job. It must be noted that not every country had or still has a production system, so importing vaccines became a necessity, which further added to the costs borne by that country’s government. Another factor that become somewhat of an issue for the national governments was the very nature of the vaccine. The need for transport and storage at extremely low temperatures for the likes of Pfizer, Moderna, mRNA vaccines has spelled a massive logistical nightmare. While there are continuous efforts to ensure more and more people get their jab, distribution to areas, not running high enough on resources to facilitate the cold storage requirements, is becoming an impassable obstacle. To deal with this situation, Oramed Pharmaceuticals and Premas Biotech have decided to make a collaborative effort towards developing an oral alternative of the Covid 19 vaccine, Oravax Medical
This collaboration will see Oramed’s proprietary POD oral delivery technology constructing a perfect complement for Premas’ unique vaccine technology. This will not only help in bypassing the barriers surrounding the distribution network, but also this alternative is touted to be a better answer for several Covid variants out there. In addition, most of the vaccinated individuals reported certain side effects. This has been put down to our body repelling the foreign substances being directly injected into the bloodstream. Oravax will likely remedy that issue. Easier and more economical administration is expected to allow Oravax to become the primary vaccination medium for Covid 19.
